Back to Journals » Neuropsychiatric Disease and Treatment » Volume 8

A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteins

Total article views   Abstract views HTML views PDF downloads Totals
8,664 Dovepress* 6,642 435+ 1,741 7,077
PubMed Central* 17 1,570 576 1,587
Totals 6,659 2,005 2,317 8,664
*Since 23 December 2011
+Since July 2016

View citations on PubMed Central and Google Scholar